year 17, Issue 3 (May - June 2023)                   Iran J Med Microbiol 2023, 17(3): 373-376 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hosseini M J, Ghorbani S, Momeni S, Ranjbar R. COVID-19 and Kawasaki Disease: Kawasaki-Like Disease Case Report in Iran. Iran J Med Microbiol 2023; 17 (3) :373-376
1- Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
2- Department of Virology, Faculty of Medicine, Iran University of Medical Science, Tehran, Iran
3- Department of Pediatrics, Erfan Niayesh Hospital, Tehran, Iran
4- Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran ,
Abstract:   (1135 Views)

During the Coronavirus disease 2019 (COVID-19) pandemic, children are less affected than adults, and underlying conditions and older age are associated with severe disease. Following the SARS-CoV-2 pandemic, outbreaks of cases with Kawasaki-like disease and a few others with the multisystem inflammatory syndrome in children related to COVID-19 (MIS-C) have been reported. Here, we report a two-year-old girl initially admitted to urgent pediatric care and was diagnosed with Kawasaki disease associated with COVID-19 infection to highlight the clinical features and signs. Physical examination showed a fussy infant with swelling of the hands, feet, and lips, red lips, restlessness, anorexia, and fever. According to the clinical and laboratory findings, Kawasaki disease was diagnosed. Laboratory tests for SARS-CoV-2 were positive. The patient's clinical symptoms improved after receiving medications such as IVIG and ascorbic acetyl acid.

Full-Text [PDF 421 kb]   (367 Downloads) |   |   Full-Text (HTML)  (214 Views)  
Type of Study: Case report Article | Subject: Medical Virology
Received: 2022/10/25 | Accepted: 2023/02/28 | ePublished: 2023/06/26

1. Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19. Infez Med. 2020;28(suppl 1):6-17.
2. Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19. J Cell Physiol. 2021;236(1):49-54. [DOI:10.1002/jcp.29868] [PMID] [PMCID]
3. Arefinia N, Ghoreshi Z-a-S, Alipour AH, Reza Molaei H, Samie M, Sarvari J. Gastrointestinal Manifestations in Patients Infected with SARS-CoV-2. Iran J Med Microbiol. 2022;16(4):271-81. [DOI:10.30699/ijmm.16.4.271]
4. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225-8. [DOI:10.1016/S0140-6736(20)30627-9] [PMID]
5. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. [DOI:10.1111/apa.15270] [PMID] [PMCID]
6. Sharifi Luyeh M, Ashraf A, Souri Z, Mojtahedi A, Ansar MM. Clinical Features and Predictors associated with Mortality in Non-Survived Patients of COVID-19 in a Referral Hospital in Rasht, North of Iran. Iran J Med Microbiol. 2022;16(3):259-66. [DOI:10.30699/ijmm.16.3.259]
7. Esposito S, Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr Drugs. 2021(2):119-29. [DOI:10.1007/s40272-020-00435-x] [PMCID]
8. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8. [DOI:10.1016/S0140-6736(20)31103-X] [PMID]
9. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10(6):537-40. [DOI:10.1542/hpeds.2020-0123] [PMID]
10. Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract. 2020;40:101214. [DOI:10.1016/j.ctcp.2020.101214] [PMID] [PMCID]
11. Torabi R, Ranjbar R, Halaji M, Heiat M. Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review. Mol Cell Probes. 2020;53:101636. [DOI:10.1016/j.mcp.2020.101636] [PMID] [PMCID]
12. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;45(6):e20200702. [DOI:10.1542/peds.2020-0702] [PMID]
13. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370-1. [DOI:10.1056/NEJMc2003717] [PMID] [PMCID]
14. Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11(8):475. [DOI:10.1038/nrrheum.2015.54] [PMID]
15. Turnier JL, Anderson MS, Heizer HR, Jone P-N, Glodé MP, Dominguez SR. Concurrent respiratory viruses and Kawasaki disease. Pediatrics. 2015;136(3):e609-e4. [DOI:10.1542/peds.2015-0950] [PMID]
16. Cazzaniga M, Baselli LA, Cimaz R, Guez SS, Pinzani R, Dellepiane RM. SARS-COV-2 Infection and Kawasaki Disease: Case Report of a Hitherto Unrecognized Association. Front Pediatr. 2020;8:398. [DOI:10.3389/fped.2020.00398] [PMID] [PMCID]
17. Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, et al. Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020;40(12):2105-15. [DOI:10.1007/s00296-020-04701-6] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Medical Microbiology

Designed & Developed by : Yektaweb | Publisher: Farname Inc